Parkinson's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of both PD and RBD; (2) Hoehn-Yahr rating 2.5 period; (3) The score of MMSE was >22 points; (4) If receiving anti-PD drug treatment, the dose should be stable for at least 30 days; (5) Have a good reading comprehension ability, can fill in the scale by themselves or with the help of researchers; (6) All patients are required to submit informed consent before participating in the study.
Exclusion criteria
Exclusion criteria: (1) Patients with various secondary PD and Parkinson's syndrome; (2) Complicated with serious cardiovascular and cerebrovascular, liver, kidney and lung organ and tissue diseases, malignant tumors, mental disorders, etc.; (3) Taking sedatives or other methods related to RBD within the last 1 month; (4) Patients who have undergone deep brain stimulation; (5) There are contraindications such as skin damage and blood system diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep status;quality of life; | — |
Secondary
| Measure | Time frame |
|---|---|
| mood;Changes in condition; | — |
Countries
China
Contacts
Nanjing University of Chinese Medicine; Changshu City Hospital of Traditional Chinese Medicine